Day-1 Sep-18, 2014 |
Track -1 |
|
1 |
Creating & Implementing a Sustainable Quality Culture |
Mr S M Mudda, Executive Director - Technical & Operations, Micro Labs Limited |
|
|
2 |
Data Integrity - Regulatory Perspective |
Dr Ajaz Hussain, Insight Advice & Solutions LLC |
|
|
3 |
Regulatory Health Authority expectations for Chromatography Laboratories |
Ms Heather Longden, Senior Marketing Manager, Waters Corporation |
|
|
4 |
Quality Risk Management - A Practical Approach |
Mr Eduardo Heidelberg, Managing Principal, QRM Consultants LLC |
|
|
5 |
Product Quality Life Cycle Implementation - Foundation of Product Quality |
Mr Bruce Davis, Consultant, UK |
|
|
6 |
Laboratory Investigations - Leading to Root Cause |
Dr Suraj B Baloda, Founder & President, Sarmicon LLC |
|
Track -2 |
| 1 |
Why India needs Orphan Drug & Rare Diseases Policy |
Prof Muthyala Ramaiah, President / CEO, Indian Organization for Rare Diseases |
|
| 2 |
Rare Diseases in India: Orphan Seeking Attention |
Dr Y K Gupta, Prof & Head, Dept. of Pharmacology, AIIMS |
|
| 3 |
Canadian Organization for Rare Diseases |
Dr Durhane Wong Reiger, President & CEO, Canadian Organization for Rare Disorders |
|
| 4 |
Dichotomy of Rare Diseases |
Dr Hugh Dawkins, Director, Office of Population Health Genomics, Department of Health, Western Australia |
|
| 5 |
Orphan Drugs - Indian Perspective |
Dr Eswara Reddy, Dy. Drugs Controller(I), CDSCO |
|
Day-2 Sep-19, 2014 |
Track -1 |
|
|
Track -2 |
| |
|
|
